单位:[1]School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.[2]Department of Thoracic Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.临床科室胸外科胸外科首都医科大学附属北京友谊医院
Background Tumor microenvironment (TME) critically contributed to the malignant progression of transformed cells and the chemical responses to chemotherapy reagents. Osteopontin (OPN) is a secretory onco-protein with several splicing isoforms, all of which were known to regulate tumor growth and able to alter cell-cell or cell-TME communication, however, the exact role and regulation of the OPN splicing isoforms was not well understood. Methods In this study, the effects of conditioned medium from the culture of OPN splicing isoforms overexpressing cells on cell functions were evaluated. The methods of nuclear calcium reporter assays and subcellular distribution of nuclear factor of activated T cells c2 (NFATc2) assays were used to investigate the molecular mechanism underlining the roles of OPN splicing isoforms. Results We found that the survival of NSCLC cells treated with cisplatin was increased by secretory OPNc in the condition medium, where reduction of apoptosis by OPNc was associated with the activation of cellular calcium signals and subsequent nuclear translocation of NFATc2. Conclusions The results revealed a mechanism of OPN and downstream signal for tumor cells to survive in chemo-stressed TME, which emphasized the importance of secretory proteins in alternative splicing isoforms. Our study not only demonstrated the importance of OPN neutralization for anti-tumor effects, but also implied that modulation in calcium/NFATc2/ROS axis could be a novel approach for improving the long-term outcome of NSCLC treatment.
基金:
National Natural Science Foundation of the People's Republic of ChinaNational Natural Science Foundation of China (NSFC) [82073215]
第一作者单位:[1]School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
通讯作者:
推荐引用方式(GB/T 7714):
Jing Huang,Mu Hu,Huan Niu,et al.Osteopontin isoform c promotes the survival of cisplatin-treated NSCLC cells involving NFATc2-mediated suppression on calcium-induced ROS levels[J].BMC CANCER.2021,21(1):doi:10.1186/s12885-021-08495-z.
APA:
Jing Huang,Mu Hu,Huan Niu,Jing Wang,Yang Si...&Wei Ding.(2021).Osteopontin isoform c promotes the survival of cisplatin-treated NSCLC cells involving NFATc2-mediated suppression on calcium-induced ROS levels.BMC CANCER,21,(1)
MLA:
Jing Huang,et al."Osteopontin isoform c promotes the survival of cisplatin-treated NSCLC cells involving NFATc2-mediated suppression on calcium-induced ROS levels".BMC CANCER 21..1(2021)